Endocrinology
From the Journals
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’
Confusion with the term ‘diabetes mellitus’ ... has spurred proposed name change by an international panel representing major endocrinology...
Feature
The truth about the ‘happy hormone’: Why we shouldn’t mess with dopamine
Since its first synthesis in the early 20th century, dopamine has often been misunderstood and oversimplified – and it seems the story is...
Conference Coverage
Type 1 diabetes cases poised to double worldwide by 2040
Most people with existing and new-onset type 1 diabetes are adults, and much of the increase is expected in low- and middle-income countries.
Conference Coverage
Fish oil pills do not reduce fractures in healthy seniors: VITAL
The largest worldwide study to examine how fish oil supplements might reduce the risk of fractures did not find any benefit.
Conference Coverage
Hip fractures likely to double by 2050 as population ages
Greater efforts “are needed to prevent hip fractures and improve the treatment gap and post-fracture care, especially in men and the oldest old...
From the Journals
Artificial sweeteners linked to higher CV event risk
The first study to include artificial sweetener from all sources, not just drinks, may increase concerns about these agents. But not all are...
News
ACC fills gaps on guidance for nonstatin therapies for LDL-C lowering
The new guidance addresses the role of nonstatin therapies for lowering LDL-C, which were not addressed in the 2018 ACC/AHA guideline on...
Feature
Congressman’s wife died after taking herbal remedy marketed for diabetes and weight loss
Lori McClintock’s death was caused by “adverse effects of white mulberry leaf ingestion,” according to the coroner’s report.
From the Journals
Early menopause linked with increased risk of heart problems
A study of more than 1.4 million women revealed that the younger the age at menopause, the higher the risk of heart failure and atrial...
From the Journals
Metformin fails as early COVID-19 treatment but shows potential
Metformin may merit further investigation for adults who are overweight or obese.
From the Journals
Rosuvastatin again linked with risks to kidneys
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...